Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
about
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspectiveAn overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.PharmGKB summary: pazopanib pathway, pharmacokinetics.Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway.A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study.
P2860
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@ast
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@en
type
label
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@ast
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@en
prefLabel
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@ast
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@en
P2093
P2860
P1476
Phase Ib trial of the oral ang ...... ts with advanced solid tumors.
@en
P2093
A Benjamin Suttle
Alex A Adjei
Chun-Fang Xu
Grace K Dy
Howard A Burris
Jeffrey R Infante
Johanna C Bendell
Lone H Ottesen
Qiong Wang
P2860
P2888
P304
P356
10.1007/S10637-012-9900-0
P577
2012-11-22T00:00:00Z
P5875
P6179
1021141792